Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlled and Randomized Clinical Trial for Evaluating the Effect of a Supplement of Glycine as Adjuvant in the Treatment of COVID-19 Pneumonia in Patients Initiating Mechanical Ventilation

NCT04443673 is registered in ClinicalTrials.gov with Instituto Nacional de Enfermedades Respiratorias as lead sponsor.

NCT NCT04443673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04443673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlled and Randomized Clinical Trial for Evaluating the Effect of a Supplement of Glycine as Adjuvant in the Treatment of COVID-19 Pneumonia in Patients Initiating Mechanical Ventilation
Lead sponsor
Instituto Nacional de Enfermedades Respiratorias
Phase
Not applicable
Overall status
Terminated
Start date
June 15, 2020
Completion date
June 14, 2021
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, human, covid-19, pneumonia, viral, sars (severe acute respiratory syndrome), sars pneumonia, sars-cov infection